The tumorsusceptibilitygene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function

Y. Qin, Y. Deng, C. J. Ricketts, S. Srikantan, E. Wang, E. R. Maher, P. L.M. Dahia

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

TMEM127 is an endosome-associated tumor suppressor gene in pheochromocytomas, neuroendocrine tumors that can co-occur with renal cell carcinomas (RCCs). TMEM127 loss leads to increased mTOR signaling. However, the spectrum of tumors with TMEM127 mutation and how TMEM127 and mTOR interact in tumorigenesis remains unknown. Here, we report that germline TMEM127 mutations occur in RCCs and that somemutant proteins, unlike wild-type (WT) TMEM127, fail to cooperate with activated early endosomal GTPase, Rab5, to inhibit mTOR signaling. Tmem127-null mouse embryonic fibroblasts (MEFs) are deficient in generating earlyto- late hybrid endosomes upon constitutive Rab5 activation, a defect rescued by WT, but not mutant, TMEM127. This endosomal dysfunction results in diminishedmTORcolocalization with Rab5-positive vesicles. Conversely, active, lysosomal-bound mTOR is increased in Tmem127-null MEFs, which also display enhanced lysosomal biogenesis. Our data map the tumor-suppressive properties of TMEM127 to modulation of mTOR function in the endolysosome, a feature thatmaycontribute to bothpheochromocytomaandRCCpathogenesis.

Original languageEnglish (US)
Article numberddt638
Pages (from-to)2428-2439
Number of pages12
JournalHuman molecular genetics
Volume23
Issue number9
DOIs
StatePublished - May 2014

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'The tumorsusceptibilitygene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function'. Together they form a unique fingerprint.

Cite this